Polycomb group proteins (PcG) are a group of transcriptional repressors that silence gene transcription through covalent modification of histone proteins and compaction of chromatin at target genes. In metazoans, PcG proteins are present in all cells of the body and at all stages of development, but they repress target genes only in cells where these genes should remain inactive. Work over the past decades led to the general view that PcG proteins do not initiate repression but primarily function to preserve the transcriptionally inactive state of a target gene in situations where transcriptional activators of this gene are present in a cell but the gene nevertheless needs to remain inactive. Classic examples of this type of regulation are the long-term repression of Hox genes in inappropriate body segments during Drosophila development. Repression of a target gene by PcG proteins does, however, not always mean terminal silencing of the gene in a given cell; in many instances repression needs to be reversed, even after prolonged periods of silencing. In PNAS, Erokhin et al. (1) address how PcGregulated transgenes respond to the presence of a transcriptional activator. Understanding how a PcG-repressed state is converted into a transcriptionally active state is not only important for understanding how genes are regulated during normal development but also for understanding the events that occur when PcG proteins malfunction in cancer.
In their experiments, Erokhin et al. (1) analyzed the consequences of bringing the transcriptional activator Gal4 to a transgene construct in which PcG proteins, bound to a Polycomb response element (PRE), normally repress transcription from linked reporter genes. The 660-bp bxd PRE used in this study is a well-characterized PRE from the HOX gene Ubx (2-4). A simplified version of the transgene and the key conclusions from their studies are shown in Fig. 1 . Erokhin et al. (1) found that continuous Gal4 expression is able to disrupt transcriptional repression mediated by the PRE, and they demonstrate that this process does not require transcription through the PRE. Moreover, the authors show that transcription through the PRE in the transgene does not cause displacement of PcG proteins. This study thus refutes a popular model that posits that transcription through a PRE would cause PcG proteins to be displaced and would be a key step in "switching" a PRE into a cis-regulatory element with enhancer-like properties (Fig. 1) . To understand the relevance of the work by 
In 1998, Cavalli and Paro (5) reported that in a transgene containing Fab-7, a cis-regulatory element from the Hox gene Abd-B harboring a PRE, a single short pulse of Gal4 during embryogenesis could convert repression mediated by this element into activation that was maintained throughout the animal's life. These and a number of follow-up studies (6, 7) led to the idea that transcription induces PREs to switch from a silencing to an activating element that heritably maintained that activating capacity also when the Gal4 protein was no longer present (Fig. 1E ). There were a number of issues with this interpretation. First, the 3.6-kb Fab-7 DNA fragment used contained not only a PRE but also an insulator and other regulatory DNA. Second, there was only a single transgenic line analyzed that displayed this particular "switch" property and, as reported later (8), it contained an almost perfectly duplicated transgene. In 2005, Schmitt, Prestel, and Paro (9) reported that transcription through the same Fab-7 fragment (again 3.6 kb) caused switching from a repressor to an activator, but only if the transcription was continuous, at least through embryogenesis, and the authors proposed that PcG proteins would be knocked off by transcription through PREs. With their data, Erokhin et al. (1) argue that this is not the case because even prolonged transcription through the PRE in their transgene does not result in displacement of PcG protein complexes. Does persistent transcription through PREs permanently displace Polycomb proteins in their native chromosomal context? Currently there is no evidence that this would be the case. PcG protein complexes are bound at intronic PREs of HOX genes in cells where these genes are actively transcribed, both in developing Drosophila (10-12) and in tissue culture cells (13) . Similar to the situation at the reporter gene in the Erokhin et al. study (1) , the level of PcG protein binding at such intronic PREs is somewhat reduced when analyzed by chromatin immunoprecipitation, suggesting that the act of transcription may to some extent interfere with PcG complex binding, but certainly does not result in complete removal of these protein complexes.
Nevertheless, in the context of their native chromosomal location, many PREs are transcribed into noncoding RNAs (9, 14, 15) . To date, the functional significance of such a PRE RNA has only been tested in one case. In particular, Pease et al. (16) This transcript is expressed in the same domain as Ubx and might be expected to antagonize bxd PRE-bound PcG protein binding and silencing activity. Pease et al. found that eliminating transcription through the bxd PRE caused no defect in Ubx expression or any other aspect of fly development (16) . So, at least in this case, transcription through the PRE does not appear to be physiologically relevant to antagonize the silencing capacity of this element.
A last point deserving discussion comes from the observation by Erokhin et al. (1) that binding of Gal4 to the transgene is able to overcome repression mediated by the PRE and restore normal levels of white gene transcription. It should be noted that in their transgene, the Gal4 protein binding sites are located 8 kb and 1.7 kb away from the white gene and the PRE, respectively, and that, at least in yeast, Gal4 is unable to activate transcription at this distance (17) . The most straightforward interpretation is that upon binding of Gal4, the PRE is no longer able to mediate its repressing effect on the white gene and that it is white regulatory sequences that activate white gene transcription. Erokhin et al. (1) found that in the presence of Gal4, the amount of GAGA Factor and Trithorax protein binding at the PRE increased substantially, again, regardless of whether the PRE was transcribed or not. At present, it is not known what exactly these proteins do at PREs and why their binding at PREs is increased in the presence of Gal4, but it is possible that they are part of the mechanism that interferes with the silencing capacity of PRE-bound PcG proteins. Finally, it is important to recall that deletion of the bxd PRE from the Ubx gene results in misexpression but not loss of expression of Ubx (4). Taking all this together, the available evidence thus suggests that PREs solely act as regulatory sequences that silence transcription and that they lack enhancer-like properties to activate transcription.
